Basit öğe kaydını göster

dc.contributor.authorInanc, Yusuf
dc.contributor.authorArlier, Zulfikar
dc.contributor.authorInanc, Yilmaz
dc.contributor.authorGeyik, Sirma
dc.contributor.authorGiray, Semih
dc.contributor.authorKocaturk, Ozcan
dc.date.accessioned2019-12-06T10:40:20Z
dc.date.available2019-12-06T10:40:20Z
dc.date.issued2015
dc.identifier.issn2564-7784
dc.identifier.urihttps://pdfs.semanticscholar.org/7c66/34d9b9f0cc7e7f9a3dc5dd836c46cb220f24.pdf?_ga=2.87600856.1169836494.1575627835-906815829.1574851467
dc.identifier.urihttp://hdl.handle.net/11727/4343
dc.description.abstractCreutzfeldt-Jakob disease (CJD) is among very rare, progressive, untreatable, neurodegenerative prion diseases. While the incidence is reported as 1/1000000 years in European countries, sporadic cases are rarely presented in Turkey. Clinical findings are in the form of rapid progressive dementia, myoclonus, cerebellar, pyramidal and extra pyramidal symptoms. Definitive diagnosis is established by histopathological examination. Our case is a 64-year-old male and 70-year-old female patients admitted with dizziness emerged as sub-acute weakness, nausea, vomiting, insomnia, imbalance and additional neuropsychiatric complaints. Focal activity slowness and common periodic sharp wave activities were observed in EEG. CJD was considered because bilateral symmetrical diffusion limitation was observed at both sides in the basal ganglia level in cranial diffusion MRI's and 14-3-3 protein was resulted as positive in CSF examinations. CJD, which is a very rare disease in patients presenting with progressive neuropsychiatric symptoms and seizure, is one of the diagnosis to be considered and we wanted to emphasize that there is no treatment for it and preventive measures should be taken.en_US
dc.language.isoturen_US
dc.relation.isversionof10.5455/GMJ-30-173253en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCreutzfeldt-Jakob diseaseen_US
dc.subjectdementiaen_US
dc.subjectmyoclonusen_US
dc.titleCreutzfeldt-Jakob disease presented with dizziness, weakness and neuropsychiatric symptoms: 2 Case Reportsen_US
dc.typearticleen_US
dc.relation.journalEUROPEAN JOURNAL OF THERAPEUTICSen_US
dc.identifier.volume21en_US
dc.identifier.issue2en_US
dc.identifier.startpage142en_US
dc.identifier.endpage146en_US
dc.identifier.wos000439230200013en_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergien_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster